Abstract:Cardiomyopathies, encompassing hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM), constitute a diverse spectrum of heart muscle diseases that often culminating in heart failure (HF). The inherent molecular heterogeneity of these conditions has implications for prognosis and therapeutic strategies. Publicly available microarray and RNA sequencing (RNA-seq) data sets of HCM (n = 106 from GSE36961) and DCM (n = 18 from GSE135055 and 166 from GSE141910) patients were employed for our analysis. The Non-negative Matrix Factorization (NMF) algorithm was applied to explore the molecular stratification within HCM and DCM, and enrichment analysis was performed to delineate their biological characteristics. By integrating bulk and single-nucleus RNA-seq (snRNA-seq) data, we identified a potential biomarker for HCM progression and cardiac fibrosis, which was subsequently validated using mendelian randomization and in vitro. Our application of NMF identified two distinct molecular clusters. Particularly, a profibrotic, heart failure with reduced ejection fraction (HFrEF)-resembling Cluster 1 emerged, characterized by diminished expression of CORIN and a high degree of fibroblast activation. This cluster also exhibited lower left ventricular ejection fraction (LVEF) and worse prognostic outcomes, establishing the significance of this molecular subclassification. We further found that overexpression of CORIN could mitigate TGFβ1-induced expression of col1a1 and α-SMA in neonatal rat cardiac fibroblasts. Our results indicated the heterogeneity of HCM population, and further evidenced the participation of corin in the progression of HCM, DCM and HFrEF. Nevertheless, our study is constrained by the lack of corresponding clinical data and experimental validation of the identified subtypes. Therefore, further studies are warranted to elucidate the downstream pathways of corin and to validate these findings in independent patient cohorts.

Corin deficiency impairs cardiac function in mouse models of heart failure

Recombinant Soluble Corin Improves Cardiac Function in Mouse Models of Heart Failure

Protease corin expression and activity in failing hearts.

Corin Variant Associated With Hypertension And Cardiac Hypertrophy Exhibits Impaired Zymogen Activation And Natriuretic Peptide Processing Activity

Impaired Sodium Excretion and Salt-Sensitive Hypertension in Corin-Deficient Mice

Renal Corin Is Essential for Normal Blood Pressure and Sodium Homeostasis

Hypertension In Mice Lacking The Proatrial Natriuretic Peptide Convertase Corin

Upregulation of Corin Gene Expression in Hypertrophic Cardiomyocytes and Failing Myocardium

Corin in Natriuretic Peptide Processing and Hypertension

Corin in Clinical Laboratory Diagnostics

Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy

Salt-sensitive hypertension and cardiac hypertrophy in transgenic mice expressing a corin variant identified in blacks.

Progression from cardiomyopathy to heart failure with reduced ejection fraction: A CORIN deficient course

Corin: new insights into the natriuretic peptide system.

Function and Regulation of Corin in Physiology and Disease.

The Serine Protease Corin in Cardiovascular Biology and Disease

Corin: A Key Mediator in Sodium Homeostasis, Vascular Remodeling, and Heart Failure

Deficiencies in Corin and Atrial Natriuretic Peptide-Mediated Signaling Impair Endochondral Ossification in Bone Development

Corin Deficiency Diminishes Intestinal Sodium Excretion in Mice

Corin Mutation R539C from Hypertensive Patients Impairs Zymogen Activation and Generates an Inactive Alternative Ectodomain Fragment

A common CORIN variant in hypertension reduces corin intracellular trafficking by exposing an inhibitory N-terminus